Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649568 · ClinicalTrials.gov registry record · NA
Protein Source on Plasma Amino Acid Concentrations
A NA study of Protein Deposition, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03649568: Completed NA study of Protein Deposition, sponsored by Purdue University.
NCT03649568 is a NA study of Protein Deposition that has completed, run by Purdue University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03649568, a NA study of Protein Deposition, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effect of the same ounce-equivalents of fresh pork versus nuts, beans, and eggs on postprandial plasma essential amino acid availability in adults. Each participant will receive all four treatments.
Primary Outcome
Plasma samples will be drawn at times 0, 30, 60, 120, 180, 240, and 300 minutes after the consumption of the trial meal.
Conditions Studied
Interventions
- OTHER Almonds
- OTHER Pork
- OTHER Egg
- OTHER Black beans
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-08-24 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
What the finished NCT03649568 record still lists
NCT03649568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Protein Deposition appearing as the primary indexed condition, and to 4 interventions - of which Almonds is the first listed.
NCT03649568 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03649568 about?
NCT03649568 is a clinical study titled "Protein Source on Plasma Amino Acid Concentrations". This study will determine the effect of the same ounce-equivalents of fresh pork versus nuts, beans, and eggs on postprandial plasma essential amino acid availability in adults. Each participant will receive all four treatments.
What is the current status of trial NCT03649568?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-08-24. Estimated completion is 2020-03-31.
What conditions does trial NCT03649568 study?
This clinical trial studies the following conditions: Protein Deposition.
What interventions are being tested in trial NCT03649568?
The interventions under investigation include: Almonds (OTHER), Pork (OTHER), Egg (OTHER), Black beans (OTHER).
Who is sponsoring clinical trial NCT03649568?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03649568 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03649568's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI